Dr. Sandra Verelst
Enterprise number 0804259068 · Active (000 Normale toestand)
Dr. Sandra Verelst is a besloten vennootschap registered in Nijlen, Belgium, incorporated on 25 Jul 2023. Its registered activity is activiteiten van medisch specialisten.
Company details
- Enterprise number
- 0804259068 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 25 Jul 2023 (3 years)
- Registered address
- 2560 Nijlen
- Province
- Antwerp
- Activity
- 86220 Activiteiten van medisch specialisten
- Industry
- Human health activities
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Antwerp
- "PRAKTIJK 't KEERPUNT Sint-Katelijne-Waver
- "Thuisverpleging Bart Hus" Mol
- 'Huisartsengroepspraktijk ‘De Kouwelaar’’ Antwerpen
- 't Vlinderhuisje Putte
- 't praktijkHU!S. Meerhout
- 2 MOVE ON Schoten
- 2 Move Schoten
- 2182 Antwerpen
- 2Arts Edegem
- 2IZ Willebroek
- 2thepoint, begeleiding rondom autisme Oud-Turnhout
- 4D CONSULTANCY Kasterlee
Questions about Dr. Sandra Verelst
What is the enterprise number of Dr. Sandra Verelst?
Dr. Sandra Verelst is registered under enterprise number 0804259068 in the official register of Belgium. View it at the official register.
Is Dr. Sandra Verelst still active?
Yes. Dr. Sandra Verelst is registered as active (status: 000 Normale toestand).
Has Dr. Sandra Verelst gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for Dr. Sandra Verelst in the official data.
When was Dr. Sandra Verelst founded?
Dr. Sandra Verelst was incorporated on 25 Jul 2023.
Where is Dr. Sandra Verelst registered?
Dr. Sandra Verelst's registered address is in 2560 Nijlen (Antwerp), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.